TOPICAL COMPOSITIONS FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS

The present invention relates to a composition comprising a combination of a (halogenoacetamido)benzoate, a flavonol and a terpene, and, as exemple, relates to a composition comprising the combination of ethyl 3-(2-chloroacetamido)benzoate, dihydroquercetin and bisabolol. Said composition is for use...

Full description

Saved in:
Bibliographic Details
Main Authors LE PAPE, Patrice, FELLOUS, Esther, AUCLAIR, Christian, KALIL-FILHO, Jorge E
Format Patent
LanguageEnglish
French
Published 07.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a composition comprising a combination of a (halogenoacetamido)benzoate, a flavonol and a terpene, and, as exemple, relates to a composition comprising the combination of ethyl 3-(2-chloroacetamido)benzoate, dihydroquercetin and bisabolol. Said composition is for use in the treatment of leishmaniasis, especially cutaneous or mucosal leishmaniasis, the composition being applied topically for concomitantly treating both parasitic infection and skin inflammation of the infected area induced by leishmaniasis. La présente invention concerne une composition comprenant une combinaison d'(halogénoacétamido)benzoate, de flavonol et de terpène, et, par exemple, concerne une composition comprenant la combinaison de 3-(2-chloroacétamido)benzoate d'éthyle, dihydroquercétine et bisabolol. Ladite composition est destinée à être utilisée dans le traitement de la leishmaniose, notamment la leishmaniose cutanée ou mucosale, où la composition est appliquée de manière topique pour le traitement concomitant à la fois de l'infection parasitaire et de l'inflammation cutanée de la zone infectée induite par la leishmaniose.
Bibliography:Application Number: WO2018EP73576